Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

1.

Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness.

Kreyenbuhl J, Dickerson FB, Medoff DR, Brown CH, Goldberg RW, Fang L, Wohlheiter K, Mittal LP, Dixon LB.

J Nerv Ment Dis. 2006 Jun;194(6):404-10.

PMID:
16772856
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.

Ferdinand KC.

J Cardiometab Syndr. 2006 Spring;1(2):133-40. Review.

PMID:
17679832
[PubMed - indexed for MEDLINE]
3.

Metabolic syndrome: treatment of hypertensive patients.

Israili ZH, Lyoussi B, Hernández-Hernández R, Velasco M.

Am J Ther. 2007 Jul-Aug;14(4):386-402. Review.

PMID:
17667215
[PubMed - indexed for MEDLINE]
4.

[Combined antihypertensive and antilipemic therapy as one of the pillars in the poly-pharmacologic preventive strategy for patients with high cardiovascular risk].

Kékes E.

Orv Hetil. 2008 Sep 28;149(39):1827-37. doi: 10.1556/OH.2008.28457. Review. Hungarian.

PMID:
18805771
[PubMed - indexed for MEDLINE]
Free Article
5.

Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis.

Osborn DP, Wright CA, Levy G, King MB, Deo R, Nazareth I.

BMC Psychiatry. 2008 Sep 25;8:84. doi: 10.1186/1471-244X-8-84. Review.

PMID:
18817565
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Use of lipid-lowering drugs and blood pressure control in patients with arterial hypertension.

Borghi C, Dormi A, Veronesi M, Immordino V, Ambrosioni E.

J Clin Hypertens (Greenwich). 2002 Jul-Aug;4(4):277-85. Review.

PMID:
12147931
[PubMed - indexed for MEDLINE]
7.

Insulin resistance, diabetes, hypertension, and renin-angiotensin system inhibition: reducing risk for cardiovascular disease.

Fonseca VA.

J Clin Hypertens (Greenwich). 2006 Oct;8(10):713-20; quiz 721-2. Review.

PMID:
17028485
[PubMed - indexed for MEDLINE]
8.

Optimal medical management of peripheral arterial disease.

Rice TW, Lumsden AB.

Vasc Endovascular Surg. 2006 Aug-Sep;40(4):312-27. Review.

PMID:
16959725
[PubMed - indexed for MEDLINE]
9.

Pharmacological approach to cardiovascular risk in metabolic syndrome.

Bellis A, Trimarco B.

J Cardiovasc Med (Hagerstown). 2013 Jun;14(6):403-9. doi: 10.2459/JCM.0b013e32835dbd0d. Review.

PMID:
23337396
[PubMed - indexed for MEDLINE]
10.

Cardiovascular drugs as antidiabetic agents: evidence for the prevention of type 2 diabetes.

Macfarlane DP, Paterson KR, Fisher M.

Diabetes Obes Metab. 2008 Jul;10(7):533-44. doi: 10.1111/j.1463-1326.2007.00735.x. Epub 2008 Feb 1. Review.

PMID:
18248492
[PubMed - indexed for MEDLINE]
11.

Improving cardiovascular health outcomes through the use of evidence-based medicine.

Douglas J.

Ethn Dis. 2005 Spring;15(2 Suppl 2):S23-6. Review.

PMID:
15822833
[PubMed - indexed for MEDLINE]
12.
13.

Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.

Nesto RW.

Am J Cardiovasc Drugs. 2005;5(6):379-87. Review.

PMID:
16259526
[PubMed - indexed for MEDLINE]
14.

Should angiotensin II receptor blockers and statins be combined?

Nickenig G.

Circulation. 2004 Aug 24;110(8):1013-20. Review. No abstract available.

PMID:
15326080
[PubMed - indexed for MEDLINE]
Free Article
15.

Treating hypertension with cardioprotective therapies: the role of ACE inhibitors, ARBs, and beta-blockers.

Staffileno BA.

J Cardiovasc Nurs. 2005 Sep-Oct;20(5):354-64. Review.

PMID:
16141781
[PubMed - indexed for MEDLINE]
16.

Valsartan: more than a decade of experience.

Black HR, Bailey J, Zappe D, Samuel R.

Drugs. 2009;69(17):2393-414. doi: 10.2165/11319460-000000000-00000. Review.

PMID:
19911855
[PubMed - indexed for MEDLINE]
17.

Management of hypertension in patients with chronic kidney disease and diabetes mellitus.

Palmer BF.

Am J Med. 2008 Aug;121(8 Suppl):S16-22. doi: 10.1016/j.amjmed.2008.05.018. Review.

PMID:
18638614
[PubMed - indexed for MEDLINE]
18.

Treatment of COPD: moving beyond the lungs.

Matera MG, Calzetta L, Rinaldi B, Cazzola M.

Curr Opin Pharmacol. 2012 Jun;12(3):315-22. doi: 10.1016/j.coph.2012.04.001. Epub 2012 Apr 30. Review.

PMID:
22552103
[PubMed - indexed for MEDLINE]
19.

Therapeutic approaches in the prevention of cardiovascular disease in metabolic syndrome and in patients with type 2 diabetes.

Rosenson RS, Reasner CA.

Curr Opin Cardiol. 2004 Sep;19(5):480-7. Review.

PMID:
15316457
[PubMed - indexed for MEDLINE]
20.

Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.

Jones PH.

Am J Cardiol. 2008 Dec 22;102(12A):41L-47L. doi: 10.1016/j.amjcard.2008.09.074. Review.

PMID:
19084089
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk